Cell-permeant peptide inhibitors of vasospasm and intimal hyperplasia

Documenti analoghi

• A Novel Cell Permeant Peptide Inhibitor of MAPKAP Kinase II Inhibits Intimal Hyperplasia in a Human Saphenous Vein Organ Culture Model
  di: Lopes, Luciana B., et al.
  Pubblicazione: (2010)
• Inhibition of HSP27 Phosphorylation by a Cell-permeant MAPKAP Kinase 2 Inhibitor
  di: Lopes, Luciana B., et al.
  Pubblicazione: (2009)
• Use of Brilliant Blue FCF during vein graft preparation inhibits intimal hyperplasia
  di: Osgood, Michael J., et al.
  Pubblicazione: (2016)
• Surgical vein graft preparation promotes cellular dysfunction, oxidative stress, and intimal hyperplasia in human saphenous vein
  di: Osgood, Michael J., et al.
  Pubblicazione: (2013)
• Role of the Renin–Angiotensin System in the Pathogenesis of Intimal Hyperplasia: Therapeutic Potential for Prevention of Vein Graft Failure?
  di: Osgood, Michael J., et al.
  Pubblicazione: (2012)